Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher R. Gordon currently holds 10,461 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher R. Gordon has been a net seller of CERE stock. They have purchased $228.4M and sold $3.7B worth of shares.
Christopher R. Gordon's most recent insider trade was on Aug 1, 2024, when they sold 80,189 shares at $0.00 per share.
Christopher R. Gordon serves as Executive at Cerevel Therapeutics Holdings, Inc. (CERE). They have executed 38 insider transactions totaling $4.0B over their tenure at the company.
Christopher R. Gordon holds the position of Executive at Cerevel Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Christopher R. Gordon has shown a selling trading pattern, with $228.4M in total purchases and $3.7B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher R. Gordon was on Feb 15, 2013, when they sold $845.7M worth of HCA shares. This transaction involved 23,576,519 shares at $35.87 per share.
Christopher R. Gordon currently owns 10,461 shares of Cerevel Therapeutics Holdings, Inc. (CERE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher R. Gordon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher R. Gordon has 38 Form 4 filings on record as an insider at Cerevel Therapeutics Holdings, Inc..
Set alerts for Christopher R. Gordon and 40,000+ other insiders.